8-KItem 5.02 · Officer/Director ChangeItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements

West Pharmaceutical Services ($WST) CEO/President/Chair Eric M.

Filed with the SEC on · Summarized by InvestorsBot

West Pharmaceutical Services ($WST) CEO/President/Chair Eric M. Green informed the Board on Mar 6, 2026 of his intent to retire once a successor is hired. Company announced the decision Mar 9, 2026. 📢 #WST #Leadership #Pharma

The Board has engaged a leading executive recruiting firm to find Green’s successor; transition is expected in H2 2026. Green will remain in post until a successor is hired to ensure a smooth handover. 🔍⏳ $WST #Succession #CorporateGovernance

Investor takeaways: orderly, planned CEO succession with no immediate vacancy; monitor timing of the hire and any strategic/operational updates from $WST. 📈 $WST #InvestorAlert #Governance

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from WEST PHARMACEUTICAL SERVICES INC